Polymorphisms and Haplotypes of the Estrogen Receptor-β Gene (ESR2) and Cardiovascular Disease in Men and Women

Background: Cohort studies suggest an association between variation in the estrogen receptor-α gene (ESR1) and cardiovascular disease (CVD), but data are lacking for the effect of variation in the estrogen receptor-β gene (ESR2). Methods: Three polymorphisms of the ESR2 gene, and their associated ha...

Celý popis

Uložené v:
Podrobná bibliografia
Vydané v:Clinical chemistry (Baltimore, Md.) Ročník 53; číslo 10; s. 1749 - 1756
Hlavní autori: Rexrode, Kathryn M, Ridker, Paul M, Hegener, Hillary H, Buring, Julie E, Manson, JoAnn E, Zee, Robert YL
Médium: Journal Article
Jazyk:English
Vydavateľské údaje: Washington, DC American Association for Clinical Chemistry 01.10.2007
Predmet:
ISSN:0009-9147, 1530-8561
On-line prístup:Získať plný text
Tagy: Pridať tag
Žiadne tagy, Buďte prvý, kto otaguje tento záznam!
Abstract Background: Cohort studies suggest an association between variation in the estrogen receptor-α gene (ESR1) and cardiovascular disease (CVD), but data are lacking for the effect of variation in the estrogen receptor-β gene (ESR2). Methods: Three polymorphisms of the ESR2 gene, and their associated haplotypes, were evaluated in 296 white women from the Women’s Health Study and 566 white men from the Physicians’ Health Study who developed CVD [myocardial infarction (MI) or ischemic stroke], each matched 1:1 to a member of the cohort study who remained free from CVD. Blood samples and cardiovascular risk information were collected at baseline. Results: Women, but not men, who developed CVD or MI, but not ischemic stroke, were more likely to have the rs1271572 polymorphism variant T allele (P = 0.05 and 0.02) and less likely to have the rs1256049 polymorphism variant A allele (P = 0.003 and 0.004). No associations were observed for rs4986938. In conditional logistic multivariate regression, the rs1271572 variant was associated with increased odds of CVD [odds ratio (OR) = 1.49, 95% CI: 1.10–2.01] and MI (OR = 1.46, 95% CI: 0.96–2.23), whereas the rs1256049 variant was associated with decreased odds of CVD (OR = 0.37, 95% CI: 0.17–0.79) and MI (OR = 0.25, 95% CI: 0.09–0.73) in women. A common haplotype that included the rs1271572 variant was associated with a 7-fold increased risk of MI in women. Conclusions: Two tightly linked polymorphisms of ESR2 were associated with risk of CVD, particularly MI, in women but not men. Additional studies of ESR2 genetic variation and risk of CVD are warranted.
AbstractList Background: Cohort studies suggest an association between variation in the estrogen receptor-α gene (ESR1) and cardiovascular disease (CVD), but data are lacking for the effect of variation in the estrogen receptor-β gene (ESR2). Methods: Three polymorphisms of the ESR2 gene, and their associated haplotypes, were evaluated in 296 white women from the Women’s Health Study and 566 white men from the Physicians’ Health Study who developed CVD [myocardial infarction (MI) or ischemic stroke], each matched 1:1 to a member of the cohort study who remained free from CVD. Blood samples and cardiovascular risk information were collected at baseline. Results: Women, but not men, who developed CVD or MI, but not ischemic stroke, were more likely to have the rs1271572 polymorphism variant T allele (P = 0.05 and 0.02) and less likely to have the rs1256049 polymorphism variant A allele (P = 0.003 and 0.004). No associations were observed for rs4986938. In conditional logistic multivariate regression, the rs1271572 variant was associated with increased odds of CVD [odds ratio (OR) = 1.49, 95% CI: 1.10–2.01] and MI (OR = 1.46, 95% CI: 0.96–2.23), whereas the rs1256049 variant was associated with decreased odds of CVD (OR = 0.37, 95% CI: 0.17–0.79) and MI (OR = 0.25, 95% CI: 0.09–0.73) in women. A common haplotype that included the rs1271572 variant was associated with a 7-fold increased risk of MI in women. Conclusions: Two tightly linked polymorphisms of ESR2 were associated with risk of CVD, particularly MI, in women but not men. Additional studies of ESR2 genetic variation and risk of CVD are warranted.
Cohort studies suggest an association between variation in the estrogen receptor-alpha gene (ESR1) and cardiovascular disease (CVD), but data are lacking for the effect of variation in the estrogen receptor-beta gene (ESR2). Three polymorphisms of the ESR2 gene, and their associated haplotypes, were evaluated in 296 white women from the Women's Health Study and 566 white men from the Physicians' Health Study who developed CVD [myocardial infarction (MI) or ischemic stroke], each matched 1:1 to a member of the cohort study who remained free from CVD. Blood samples and cardiovascular risk information were collected at baseline. Women, but not men, who developed CVD or MI, but not ischemic stroke, were more likely to have the rs1271572 polymorphism variant T allele (P = 0.05 and 0.02) and less likely to have the rs1256049 polymorphism variant A allele (P = 0.003 and 0.004). No associations were observed for rs4986938. In conditional logistic multivariate regression, the rs1271572 variant was associated with increased odds of CVD [odds ratio (OR) = 1.49, 95% CI: 1.10-2.01] and MI (OR = 1.46, 95% CI: 0.96-2.23), whereas the rs1256049 variant was associated with decreased odds of CVD (OR = 0.37, 95% CI: 0.17-0.79) and MI (OR = 0.25, 95% CI: 0.09-0.73) in women. A common haplotype that included the rs1271572 variant was associated with a 7-fold increased risk of MI in women. Two tightly linked polymorphisms of ESR2 were associated with risk of CVD, particularly MI, in women but not men. Additional studies of ESR2 genetic variation and risk of CVD are warranted.
Cohort studies suggest an association between variation in the estrogen receptor-alpha gene (ESR1) and cardiovascular disease (CVD), but data are lacking for the effect of variation in the estrogen receptor-beta gene (ESR2).BACKGROUNDCohort studies suggest an association between variation in the estrogen receptor-alpha gene (ESR1) and cardiovascular disease (CVD), but data are lacking for the effect of variation in the estrogen receptor-beta gene (ESR2).Three polymorphisms of the ESR2 gene, and their associated haplotypes, were evaluated in 296 white women from the Women's Health Study and 566 white men from the Physicians' Health Study who developed CVD [myocardial infarction (MI) or ischemic stroke], each matched 1:1 to a member of the cohort study who remained free from CVD. Blood samples and cardiovascular risk information were collected at baseline.METHODSThree polymorphisms of the ESR2 gene, and their associated haplotypes, were evaluated in 296 white women from the Women's Health Study and 566 white men from the Physicians' Health Study who developed CVD [myocardial infarction (MI) or ischemic stroke], each matched 1:1 to a member of the cohort study who remained free from CVD. Blood samples and cardiovascular risk information were collected at baseline.Women, but not men, who developed CVD or MI, but not ischemic stroke, were more likely to have the rs1271572 polymorphism variant T allele (P = 0.05 and 0.02) and less likely to have the rs1256049 polymorphism variant A allele (P = 0.003 and 0.004). No associations were observed for rs4986938. In conditional logistic multivariate regression, the rs1271572 variant was associated with increased odds of CVD [odds ratio (OR) = 1.49, 95% CI: 1.10-2.01] and MI (OR = 1.46, 95% CI: 0.96-2.23), whereas the rs1256049 variant was associated with decreased odds of CVD (OR = 0.37, 95% CI: 0.17-0.79) and MI (OR = 0.25, 95% CI: 0.09-0.73) in women. A common haplotype that included the rs1271572 variant was associated with a 7-fold increased risk of MI in women.RESULTSWomen, but not men, who developed CVD or MI, but not ischemic stroke, were more likely to have the rs1271572 polymorphism variant T allele (P = 0.05 and 0.02) and less likely to have the rs1256049 polymorphism variant A allele (P = 0.003 and 0.004). No associations were observed for rs4986938. In conditional logistic multivariate regression, the rs1271572 variant was associated with increased odds of CVD [odds ratio (OR) = 1.49, 95% CI: 1.10-2.01] and MI (OR = 1.46, 95% CI: 0.96-2.23), whereas the rs1256049 variant was associated with decreased odds of CVD (OR = 0.37, 95% CI: 0.17-0.79) and MI (OR = 0.25, 95% CI: 0.09-0.73) in women. A common haplotype that included the rs1271572 variant was associated with a 7-fold increased risk of MI in women.Two tightly linked polymorphisms of ESR2 were associated with risk of CVD, particularly MI, in women but not men. Additional studies of ESR2 genetic variation and risk of CVD are warranted.CONCLUSIONSTwo tightly linked polymorphisms of ESR2 were associated with risk of CVD, particularly MI, in women but not men. Additional studies of ESR2 genetic variation and risk of CVD are warranted.
Author Zee, Robert YL
Rexrode, Kathryn M
Manson, JoAnn E
Hegener, Hillary H
Buring, Julie E
Ridker, Paul M
Author_xml – sequence: 1
  givenname: Kathryn M
  surname: Rexrode
  fullname: Rexrode, Kathryn M
  organization: Division of Preventive Medicine and the Center for Cardiovascular Disease Prevention
– sequence: 2
  givenname: Paul M
  surname: Ridker
  fullname: Ridker, Paul M
  organization: Division of Preventive Medicine and the Center for Cardiovascular Disease Prevention,, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA
– sequence: 3
  givenname: Hillary H
  surname: Hegener
  fullname: Hegener, Hillary H
  organization: Division of Preventive Medicine and the Center for Cardiovascular Disease Prevention,, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA
– sequence: 4
  givenname: Julie E
  surname: Buring
  fullname: Buring, Julie E
  organization: Division of Preventive Medicine and the Center for Cardiovascular Disease Prevention,, Department of Epidemiology, Harvard School of Public Health, Boston, MA, Department of Ambulatory Care and Prevention, Harvard Medical School, Boston, MA
– sequence: 5
  givenname: JoAnn E
  surname: Manson
  fullname: Manson, JoAnn E
  organization: Division of Preventive Medicine and the Center for Cardiovascular Disease Prevention,, Department of Epidemiology, Harvard School of Public Health, Boston, MA
– sequence: 6
  givenname: Robert YL
  surname: Zee
  fullname: Zee, Robert YL
  organization: Division of Preventive Medicine and the Center for Cardiovascular Disease Prevention,, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA
BackLink http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=19128196$$DView record in Pascal Francis
https://www.ncbi.nlm.nih.gov/pubmed/17702854$$D View this record in MEDLINE/PubMed
BookMark eNp9kc9uEzEQxi1URNPCGyDkCwgOG_xnvV5zQEIhtEhFoALiaDnecWPktRd7UymvxYPwTGxISoEDp9Foft83mvlO0FFMERB6SMmccsmf2-CjXUM_Z4TIOVG0FvUdNKOCk6oVDT1CM0KIqqaBPEYnpXyd2lq2zT10TKUkrBX1DA0fUtj2KQ9rX_qCTezwuRlCGrcDFJwcHteAl2XM6QoivgQLw5hy9eM7PoMI-Ony4yV79ku2MLnz6doUuwkm49e-gCmAfcTvJuWO-JJ6iPfRXWdCgQeHeoo-v1l-WpxXF-_P3i5eXVS25s1YMSncquOidYopZZWtpXVCULEiHDpmpVnV0CnqQHVGdYrJhroV70CqlnWO8FP0cu87bFY9dBbimE3QQ_a9yVudjNd_T6Jf66t0rRlpBZdsMnhyMMjp2wbKqHtfLIRgIqRN0U3LCaFSTOCjPzf9XnHz5Al4fACm55jgsonWl1tOUdZS1UxcvedsTqVkcLcI0bvM9U3mepe53mc-yV78I7N-NKNPu7t8-L_4J3HPtsE
CODEN CLCHAU
CitedBy_id crossref_primary_10_2459_JCM_0000000000000500
crossref_primary_10_3389_fendo_2019_00733
crossref_primary_10_1177_1933719110367829
crossref_primary_10_1007_s10072_011_0885_9
crossref_primary_10_1089_met_2008_0030
crossref_primary_10_2165_11635960_000000000_00000
crossref_primary_10_1016_j_clim_2008_09_017
crossref_primary_10_1016_j_psyneuen_2011_04_011
crossref_primary_10_1088_1742_6596_1246_1_012005
crossref_primary_10_1371_journal_pone_0034828
crossref_primary_10_1124_pr_107_08002
crossref_primary_10_3109_13697130902943287
crossref_primary_10_3389_fmed_2023_1047166
crossref_primary_10_1016_j_ijcard_2017_11_007
crossref_primary_10_1093_cvr_cvp187
crossref_primary_10_1371_journal_pone_0034112
crossref_primary_10_1016_j_arcmed_2017_03_015
crossref_primary_10_1016_j_cjca_2015_10_021
crossref_primary_10_1016_j_gene_2018_07_048
crossref_primary_10_1016_j_ijcard_2020_02_002
crossref_primary_10_1016_j_nicl_2021_102719
crossref_primary_10_1080_09513590802485038
crossref_primary_10_1016_j_genm_2011_05_010
crossref_primary_10_2217_WHE_10_53
crossref_primary_10_1186_1471_2156_10_55
crossref_primary_10_1038_srep43632
crossref_primary_10_1161_ATVBAHA_110_215087
crossref_primary_10_1192_bjp_bp_111_091751
crossref_primary_10_1186_s12872_021_02088_1
crossref_primary_10_1038_jhg_2009_122
crossref_primary_10_1210_jc_2017_00957
crossref_primary_10_1186_1423_0127_20_32
crossref_primary_10_1016_j_neurobiolaging_2013_09_026
crossref_primary_10_1016_j_phrs_2020_105163
crossref_primary_10_1038_cddis_2013_66
crossref_primary_10_1016_j_parkreldis_2010_02_012
crossref_primary_10_3389_fendo_2019_00310
crossref_primary_10_1016_j_meegid_2014_09_024
crossref_primary_10_1016_j_jalz_2012_12_008
crossref_primary_10_1007_s00296_012_2386_4
crossref_primary_10_1016_j_jns_2012_01_007
crossref_primary_10_1111_cen_13797
crossref_primary_10_1016_j_neuroimage_2020_117087
crossref_primary_10_1038_nrendo_2017_12
crossref_primary_10_1016_j_maturitas_2008_11_006
crossref_primary_10_1373_clinchem_2007_102400
crossref_primary_10_1007_s00296_011_1947_2
crossref_primary_10_1016_j_maturitas_2016_01_009
crossref_primary_10_1080_09513590802571118
crossref_primary_10_1007_s10552_008_9216_8
crossref_primary_10_1016_j_gene_2012_08_004
crossref_primary_10_1097_FJC_0b013e318226bd16
crossref_primary_10_1089_gtmb_2008_0129
crossref_primary_10_1177_0003319709351256
crossref_primary_10_1210_jc_2013_4472
crossref_primary_10_1016_j_jep_2013_09_018
crossref_primary_10_1016_j_arcmed_2010_10_011
crossref_primary_10_1089_gte_2008_0034
Cites_doi 10.1086/319501
10.1126/science.1065250
10.1210/jc.2005-2672
10.1093/hmg/ddg055
10.1161/01.STR.0000181088.76518.ec
10.1038/sj.ejhg.5201447
10.1007/s100380070002
10.1056/NEJM198907203210301
10.1053/meta.2001.27192
10.1016/j.amjmed.2006.07.009
10.1161/CIRCULATIONAHA.105.545913
10.1016/j.arcmed.2005.04.002
10.1097/00001573-199409000-00018
10.1161/01.CIR.101.15.1792
10.1016/j.amjhyper.2005.05.023
10.1001/jama.291.24.2969
10.1210/jc.2004-1211
10.1161/01.RES.83.2.224
10.1007/s00109-001-0311-5
10.1089/152460900318911
10.1016/S0306-3623(02)00133-7
10.1161/01.HYP.0000223064.62762.0b
10.1001/jama.290.17.2263
10.1056/NEJMoa050613
10.1590/S0100-879X2006000400004
10.1161/01.ATV.0000014424.18209.21
10.1161/01.RES.0000210578.62102.a6
10.1210/jcem.83.12.5471
10.1006/geno.1995.9003
10.1086/379378
10.1038/sj.tpj.6500272
10.1016/j.amjmed.2006.07.008
ContentType Journal Article
Copyright 2007 INIST-CNRS
Copyright_xml – notice: 2007 INIST-CNRS
DBID AAYXX
CITATION
IQODW
CGR
CUY
CVF
ECM
EIF
NPM
7X8
5PM
DOI 10.1373/clinchem.2007.091454
DatabaseName CrossRef
Pascal-Francis
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
PubMed Central (Full Participant titles)
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList CrossRef
MEDLINE
MEDLINE - Academic
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: 7X8
  name: MEDLINE - Academic
  url: https://search.proquest.com/medline
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1530-8561
EndPage 1756
ExternalDocumentID PMC2085372
17702854
19128196
10_1373_clinchem_2007_091454
Genre Research Support, Non-U.S. Gov't
Journal Article
Research Support, N.I.H., Extramural
GrantInformation_xml – fundername: NHLBI NIH HHS
  grantid: HL-26490
– fundername: NCI NIH HHS
  grantid: R01 CA040360
– fundername: NCI NIH HHS
  grantid: R01 CA047988
– fundername: NHLBI NIH HHS
  grantid: HL43851
– fundername: NCI NIH HHS
  grantid: R01 CA097193
– fundername: NCI NIH HHS
  grantid: CA-40360
– fundername: NCI NIH HHS
  grantid: R01 CA034944
– fundername: NCI NIH HHS
  grantid: CA047988
– fundername: NHLBI NIH HHS
  grantid: R01 HL043851
– fundername: NCI NIH HHS
  grantid: CA097193
GroupedDBID ---
-~X
.55
04C
0R~
18M
29B
2WC
4.4
53G
5GY
5RE
5VS
5WD
6J9
7RV
7X7
88E
88I
8AO
8C1
8FE
8FG
8FH
8FI
8FJ
8R4
8R5
AABZA
AACZT
AAPQZ
AAPXW
AAQQT
AARHZ
AAUAY
AAVAP
AAYXX
ABCQX
ABDFA
ABEJV
ABGNP
ABJCF
ABJNI
ABMNT
ABNHQ
ABOCM
ABPPZ
ABPQP
ABPTD
ABQNK
ABSQV
ABUWG
ABVGC
ABWST
ABXVV
ABXZS
ACGOD
ACIHN
ACIWK
ACPRK
ACUTJ
ACYHN
ADBBV
ADGKP
ADGZP
ADIPN
ADNBA
ADQBN
ADVEK
AEAQA
AELWJ
AEMQT
AENEX
AETBJ
AEUYN
AFFHD
AFFNX
AFFZL
AFGWE
AFKRA
AFRAH
AFXAL
AFYAG
AGINJ
AGQXC
AGUTN
AHMBA
AHMMS
AJBYB
AJEEA
AJNCP
ALMA_UNASSIGNED_HOLDINGS
ALXQX
ATGXG
AZQEC
BAWUL
BCRHZ
BENPR
BES
BEYMZ
BGLVJ
BHPHI
BKEYQ
BKSAR
BPHCQ
BTFSW
BVXVI
C1A
C45
CCPQU
CITATION
CS3
D1I
DU5
DWQXO
E3Z
EBS
EJD
ENERS
EX3
F5P
F9R
FECEO
FHSFR
FLUFQ
FOEOM
FOTVD
FQBLK
FYUFA
GAUVT
GNUQQ
H13
HCIFZ
HMCUK
H~9
IH2
INIJC
INR
JXSIZ
KB.
KBUDW
KOP
KQ8
KSI
KSN
L7B
LK5
M1P
M2P
M7R
NAPCQ
NOMLY
NU-
OAUYM
OBOKY
OCZFY
OJZSN
OPAEJ
OVD
OWPYF
PCBAR
PDBOC
PHGZM
PHGZT
PJZUB
PPXIY
PQGLB
PQQKQ
PROAC
PSQYO
Q2X
R0Z
RHI
RNS
ROX
RUSNO
S0X
TCC
TEORI
TR2
TWZ
U5U
UKHRP
UNMZH
W8F
WH7
WOQ
WOW
X7M
YBU
YHG
YSK
YWH
YXANX
ZCG
ZE2
~V8
.GJ
1KJ
AAPGJ
AAWDT
ABEFU
ACFRR
ACVCV
ACZBC
ADMTO
AFFQV
AGKRT
AGMDO
AGORE
AHGBF
AI.
AJDVS
ALIPV
APJGH
AQDSO
AVNTJ
BMSDO
EBD
EIHBH
EIHJH
EMOBN
IQODW
J5H
ML-
MVM
OBFPC
PV9
RZL
SV3
TMA
VH1
YQJ
ZGI
CGR
CUY
CVF
ECM
EIF
NPM
7X8
ARBBW
PUEGO
5PM
ID FETCH-LOGICAL-c436t-275fbd358f9299c9c47cf5515b03ed2c7ab4ed91fe9da9d92761fb3de7982df03
ISICitedReferencesCount 70
ISICitedReferencesURI http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000249879200005&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
ISSN 0009-9147
IngestDate Tue Nov 04 01:56:27 EST 2025
Sun Sep 28 08:21:07 EDT 2025
Mon Jul 21 05:52:00 EDT 2025
Mon Jul 21 09:14:28 EDT 2025
Tue Nov 18 21:01:12 EST 2025
Sat Nov 29 02:19:11 EST 2025
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 10
Keywords Estrogen receptor β
Genetic variability
Gene
Clinical biology
Sex
Cardiovascular disease
Genotype
Genetics
Biochemistry
Molecular biology
Haplotype
Polymorphism
Language English
License https://academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model
CC BY 4.0
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c436t-275fbd358f9299c9c47cf5515b03ed2c7ab4ed91fe9da9d92761fb3de7982df03
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
OpenAccessLink https://academic.oup.com/clinchem/article-pdf/53/10/1749/32690387/clinchem1749.pdf
PMID 17702854
PQID 68300175
PQPubID 23479
PageCount 8
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_2085372
proquest_miscellaneous_68300175
pubmed_primary_17702854
pascalfrancis_primary_19128196
crossref_primary_10_1373_clinchem_2007_091454
crossref_citationtrail_10_1373_clinchem_2007_091454
PublicationCentury 2000
PublicationDate 2007-10-01
PublicationDateYYYYMMDD 2007-10-01
PublicationDate_xml – month: 10
  year: 2007
  text: 2007-10-01
  day: 01
PublicationDecade 2000
PublicationPlace Washington, DC
PublicationPlace_xml – name: Washington, DC
– name: England
PublicationTitle Clinical chemistry (Baltimore, Md.)
PublicationTitleAlternate Clin Chem
PublicationYear 2007
Publisher American Association for Clinical Chemistry
Publisher_xml – name: American Association for Clinical Chemistry
References 2020022802512602900_R4
2020022802512602900_R19
2020022802512602900_R5
2020022802512602900_R6
2020022802512602900_R7
2020022802512602900_R8
2020022802512602900_R15
2020022802512602900_R9
2020022802512602900_R16
2020022802512602900_R17
2020022802512602900_R18
2020022802512602900_R11
2020022802512602900_R12
2020022802512602900_R13
2020022802512602900_R14
2020022802512602900_R30
2020022802512602900_R31
2020022802512602900_R10
2020022802512602900_R32
2020022802512602900_R1
2020022802512602900_R2
2020022802512602900_R3
2020022802512602900_R26
2020022802512602900_R27
2020022802512602900_R28
2020022802512602900_R29
2020022802512602900_R22
2020022802512602900_R23
2020022802512602900_R24
2020022802512602900_R25
2020022802512602900_R20
2020022802512602900_R21
References_xml – ident: 2020022802512602900_R20
  doi: 10.1086/319501
– ident: 2020022802512602900_R29
  doi: 10.1126/science.1065250
– ident: 2020022802512602900_R10
  doi: 10.1210/jc.2005-2672
– ident: 2020022802512602900_R32
  doi: 10.1093/hmg/ddg055
– ident: 2020022802512602900_R1
  doi: 10.1161/01.STR.0000181088.76518.ec
– ident: 2020022802512602900_R31
  doi: 10.1038/sj.ejhg.5201447
– ident: 2020022802512602900_R30
  doi: 10.1007/s100380070002
– ident: 2020022802512602900_R15
  doi: 10.1056/NEJM198907203210301
– ident: 2020022802512602900_R27
  doi: 10.1053/meta.2001.27192
– ident: 2020022802512602900_R26
  doi: 10.1016/j.amjmed.2006.07.009
– ident: 2020022802512602900_R5
  doi: 10.1161/CIRCULATIONAHA.105.545913
– ident: 2020022802512602900_R13
  doi: 10.1016/j.arcmed.2005.04.002
– ident: 2020022802512602900_R24
  doi: 10.1097/00001573-199409000-00018
– ident: 2020022802512602900_R9
  doi: 10.1161/01.CIR.101.15.1792
– ident: 2020022802512602900_R12
  doi: 10.1016/j.amjhyper.2005.05.023
– ident: 2020022802512602900_R8
  doi: 10.1001/jama.291.24.2969
– ident: 2020022802512602900_R11
  doi: 10.1210/jc.2004-1211
– ident: 2020022802512602900_R21
  doi: 10.1161/01.RES.83.2.224
– ident: 2020022802512602900_R7
  doi: 10.1007/s00109-001-0311-5
– ident: 2020022802512602900_R16
  doi: 10.1089/152460900318911
– ident: 2020022802512602900_R25
  doi: 10.1016/S0306-3623(02)00133-7
– ident: 2020022802512602900_R23
  doi: 10.1161/01.HYP.0000223064.62762.0b
– ident: 2020022802512602900_R3
  doi: 10.1001/jama.290.17.2263
– ident: 2020022802512602900_R17
  doi: 10.1056/NEJMoa050613
– ident: 2020022802512602900_R4
  doi: 10.1590/S0100-879X2006000400004
– ident: 2020022802512602900_R6
  doi: 10.1161/01.ATV.0000014424.18209.21
– ident: 2020022802512602900_R2
  doi: 10.1161/01.RES.0000210578.62102.a6
– ident: 2020022802512602900_R14
  doi: 10.1210/jcem.83.12.5471
– ident: 2020022802512602900_R18
  doi: 10.1006/geno.1995.9003
– ident: 2020022802512602900_R19
  doi: 10.1086/379378
– ident: 2020022802512602900_R22
  doi: 10.1038/sj.tpj.6500272
– ident: 2020022802512602900_R28
  doi: 10.1016/j.amjmed.2006.07.008
SSID ssj0004786
Score 2.1717658
Snippet Background: Cohort studies suggest an association between variation in the estrogen receptor-α gene (ESR1) and cardiovascular disease (CVD), but data are...
Cohort studies suggest an association between variation in the estrogen receptor-alpha gene (ESR1) and cardiovascular disease (CVD), but data are lacking for...
SourceID pubmedcentral
proquest
pubmed
pascalfrancis
crossref
SourceType Open Access Repository
Aggregation Database
Index Database
Enrichment Source
StartPage 1749
SubjectTerms Adult
Aged
Aged, 80 and over
Analytical, structural and metabolic biochemistry
Biological and medical sciences
Brain Ischemia - complications
Cardiovascular Diseases - etiology
Cardiovascular Diseases - genetics
Case-Control Studies
Cohort Studies
Estrogen Receptor beta - genetics
Female
Fundamental and applied biological sciences. Psychology
Haplotypes
Humans
Investigative techniques, diagnostic techniques (general aspects)
Male
Medical sciences
Middle Aged
Myocardial Infarction - genetics
Polymorphism, Genetic
Promoter Regions, Genetic
Risk
Sex Factors
Stroke - etiology
Stroke - genetics
White People
Title Polymorphisms and Haplotypes of the Estrogen Receptor-β Gene (ESR2) and Cardiovascular Disease in Men and Women
URI https://www.ncbi.nlm.nih.gov/pubmed/17702854
https://www.proquest.com/docview/68300175
https://pubmed.ncbi.nlm.nih.gov/PMC2085372
Volume 53
WOSCitedRecordID wos000249879200005&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
journalDatabaseRights – providerCode: PRVPQU
  databaseName: Earth, Atmospheric & Aquatic Science Database
  customDbUrl:
  eissn: 1530-8561
  dateEnd: 20220430
  omitProxy: false
  ssIdentifier: ssj0004786
  issn: 0009-9147
  databaseCode: PCBAR
  dateStart: 20021201
  isFulltext: true
  titleUrlDefault: https://search.proquest.com/eaasdb
  providerName: ProQuest
– providerCode: PRVPQU
  databaseName: Health & Medical Collection
  customDbUrl:
  eissn: 1530-8561
  dateEnd: 20220430
  omitProxy: false
  ssIdentifier: ssj0004786
  issn: 0009-9147
  databaseCode: 7X7
  dateStart: 20021201
  isFulltext: true
  titleUrlDefault: https://search.proquest.com/healthcomplete
  providerName: ProQuest
– providerCode: PRVPQU
  databaseName: Materials Science Database
  customDbUrl:
  eissn: 1530-8561
  dateEnd: 20220430
  omitProxy: false
  ssIdentifier: ssj0004786
  issn: 0009-9147
  databaseCode: KB.
  dateStart: 20021201
  isFulltext: true
  titleUrlDefault: http://search.proquest.com/materialsscijournals
  providerName: ProQuest
– providerCode: PRVPQU
  databaseName: Nursing & Allied Health Database
  customDbUrl:
  eissn: 1530-8561
  dateEnd: 20220430
  omitProxy: false
  ssIdentifier: ssj0004786
  issn: 0009-9147
  databaseCode: 7RV
  dateStart: 20021201
  isFulltext: true
  titleUrlDefault: https://search.proquest.com/nahs
  providerName: ProQuest
– providerCode: PRVPQU
  databaseName: ProQuest Central
  customDbUrl:
  eissn: 1530-8561
  dateEnd: 20220430
  omitProxy: false
  ssIdentifier: ssj0004786
  issn: 0009-9147
  databaseCode: BENPR
  dateStart: 20021201
  isFulltext: true
  titleUrlDefault: https://www.proquest.com/central
  providerName: ProQuest
– providerCode: PRVPQU
  databaseName: Public Health Database (ProQuest)
  customDbUrl:
  eissn: 1530-8561
  dateEnd: 20220430
  omitProxy: false
  ssIdentifier: ssj0004786
  issn: 0009-9147
  databaseCode: 8C1
  dateStart: 20021201
  isFulltext: true
  titleUrlDefault: https://search.proquest.com/publichealth
  providerName: ProQuest
– providerCode: PRVPQU
  databaseName: Science Database (ProQuest)
  customDbUrl:
  eissn: 1530-8561
  dateEnd: 20220430
  omitProxy: false
  ssIdentifier: ssj0004786
  issn: 0009-9147
  databaseCode: M2P
  dateStart: 20021201
  isFulltext: true
  titleUrlDefault: https://search.proquest.com/sciencejournals
  providerName: ProQuest
link http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1bb9MwFLa6DSEkhLhTLsUPTAKhjDQ3x4-0CwJNLVXYUN-ixHG0Sl0atd00_hY_hL_CX-AcJ85lmjR44MVKkzhOfL4en3N8LoS8cWIph5J5GJkrDCdzYyPhcCT5MHYsEYNOYapiE2w69edzPuv1futYmIsly3P_8pIX_5XUcA6IjaGz_0Du-qFwAo6B6NAC2aH9K8LPVkvQ52H6FpuzMgHzaVwsV2hr3WiPAFgK1it4wnvgd7IAtdvYHwf7IwsLKiuhM_gWWmgwUFFvXZfVaksHDSVnsnRlVmkc2mLuWMdbCl1PDh86ipfbhXbsnaQHLStEGMzDr4eB9u9Y_8gbM2345fCo9NdAN8aW-TZQfndq8cTaSTBIve81OgmraCwMAJdVvIW2brDaT27bCigATtcCq_K_rL9jrL-jw-U5MPEyk6fm8mVKYo1ms8WzQSfjrfUf5Cnv2rXFZpjjAgNWce6q7JcwTJkEu5vK-8oSWzs-gnaMO5feDtmzmMuRDfvjxifJYao0af0BVawnjPzhunE7stTdAnAQL7OyHst1CtNVv9-WIHV8n9yrNCD6sUTuA9KT-UNye1L5eDwiRQfAFPBFGwDTVUYBwFQDmNYA_vWTInjpW4TuO9WtC1xaAZcucgpwVXco4D4mJ5-C4_Fno6oLYgjH9rYGzFyWpLbrZyDbc8GFw0QGkr-bmLZMLcHixJEpH2aSpzFPucW8YZbYqWTct9LMtJ-Q3XyVy2eEmqlwXJThLZE50ncSYE9DVxWf8Tzhu31i6xmORJU0H2u3LCO1E8zsSNMF67myqKRLnxh1r6JMGnPD_YMO8ZpOFVz65LWmZgRoxz29OJer803k-TYKmvCiT0vaNn0ZMzE8uk9Yh-r1DZhYvnslX5yqBPNYt9dm1vObXusFudP8Z1-S3e36XL4it8TFdrFZD8gOC79jO2eq9QcK7AOyNwqmsxB-HY0OoJ1Ysz8vsPN5
linkProvider ProQuest
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Polymorphisms+and+haplotypes+of+the+estrogen+receptor-%CE%B2+gene+%28ESR2%29+and+cardiovascular+disease+in+men+and+women&rft.jtitle=Clinical+chemistry+%28Baltimore%2C+Md.%29&rft.au=REXRODE%2C+Kathryn+M&rft.au=RIDKER%2C+Paul+M&rft.au=HEGENER%2C+Hillary+H&rft.au=BURING%2C+Julie+E&rft.date=2007-10-01&rft.pub=American+Association+for+Clinical+Chemistry&rft.issn=0009-9147&rft.volume=53&rft.issue=10&rft.spage=1749&rft.epage=1756&rft_id=info:doi/10.1373%2Fclinchem.2007.091454&rft.externalDBID=n%2Fa&rft.externalDocID=19128196
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0009-9147&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0009-9147&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0009-9147&client=summon